Related Experiment Video
Updated: Aug 6, 2026
10:27
Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
Polyglandular autoimmune syndrome type 2 presenting for the first time during pregnancy
The Australian & New Zealand Journal of Obstetrics & Gynaecology
|January 16, 1999
Summary
Polyglandular autoimmune deficiency (PAD) during pregnancy can have a favorable maternal and fetal outcome. Appropriate hormone replacement and steroid therapy are crucial for managing this condition during gestation and delivery.
Area of Science:
- Endocrinology
- Reproductive Medicine
- Autoimmune Diseases
Background:
- Polyglandular autoimmune deficiency (PAD) is a rare disorder characterized by autoimmune attack on multiple endocrine glands.
- Presentation of PAD during pregnancy is uncommon and poses unique management challenges for both maternal and fetal well-being.
Observation:
- A case of polyglandular autoimmune deficiency was identified in a pregnant patient.
- The condition presented specific risks to both the mother and the developing fetus.
Findings:
- Despite the complexities of managing autoimmune endocrine disorders during pregnancy, a favorable outcome was achieved for the mother.
- The fetus experienced growth retardation, but otherwise, the pregnancy concluded successfully with appropriate medical interventions.
Implications:
- This case highlights the importance of timely diagnosis and comprehensive management of polyglandular autoimmune deficiency in pregnant individuals.
- Adequate hormone replacement therapy and steroid coverage are essential for ensuring positive maternal and fetal outcomes in such cases.
- Further research into optimizing management strategies for autoimmune endocrine diseases during pregnancy is warranted.
More Related Videos
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...